【药物名称】CVT-313
化学结构式(Chemical Structure):
参考文献No.35854
标题:Purine inhibitors of cyclin dependent kinase 2 and IkappaB-alpha
作者:Lum, R.T.; Blum, C.L.; Mackman, R.; Wick, M.M.; Schow, S.R. (CV Therapeutics, Inc.)
来源:EP 1021186; US 5866702; WO 9805335
合成路线图解说明:

The condensation of 2,6-dichloropurine (I) with 4-methoxybenzylamine (II) in butanol at 120 C gives 2-chloro-6-(4-methoxybenzylamino)purine (II), which is treated with isopropyl iodide (IV) and NaH in DMF yielding 2-chloro-9-isopropyl-6-(4-methoxybenzylamino)purine (V). Finally, this compound is condensed with diethanolamine (VI) in DMSO at 160 C.

参考文献No.436284
标题:Synthesis and activity of 2,6,9-trisubstituted purines
作者:Schow, S.R.; et al.
来源:Bioorg Med Chem Lett 1997,7(21),2697
合成路线图解说明:

The condensation of 2,6-dichloropurine (I) with 4-methoxybenzylamine (II) in butanol at 120 C gives 2-chloro-6-(4-methoxybenzylamino)purine (II), which is treated with isopropyl iodide (IV) and NaH in DMF yielding 2-chloro-9-isopropyl-6-(4-methoxybenzylamino)purine (V). Finally, this compound is condensed with diethanolamine (VI) in DMSO at 160 C.

Drug Information Express,Drug R&D,Chemical Database,Patent Search.
Copyright © 2006-2024 Drug Future. All rights reserved.Contact Us